Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

IL-21 ALTERS TFH DYNAMICS, IMPROVES FLU VACCINE RESPONSE IN OLD SIV+ NHPs UNDER ART

By Jimmy He PharmD, DScApril 28, 2020

…and CD4 memory populations. In results analyzed to date, pre-prime H3N2 HAI titers of controls (mean=1:55) did not differ from IL-21 treated animals (mean=1:100). Titers increased significantly (p=0.0018) in IL-21…

ANALYTIC TREATMENT INTERRUPTION (ATI) AFTER ALLOGENEIC CCR5-D32 HSCT FOR AML IN 2013

By Enthusiast Inc MDMarch 6, 2019

…3.5% FPR, geno2pheno), confirmed by phenotypic testing (TropChase). He had a 2nd relapse of AML in Jun/13 but after 8 courses of 5-azaC and 4 donor lymphocyte infusions CR was…

LARGE HIV CLUSTERS AMONG MEN WHO HAVE SEX WITH MEN IN THE UNITED STATES

By Jimmy He PharmD, DScApril 4, 2022

…determined the primary (>50%) risk group (based on transmission category) for each cluster. For large clusters (>25 persons) among men who have sex with men (MSM), we described size at…

173 – Repeated IL-10/PD-1 Blockades Potently Control SIV Rebound and Limit Reservoir in the Absence of ART

By Jimmy He PharmD, DScMarch 31, 2026

…reservoir, while limiting treatment burden. Methods 17 RMs infected with barcoded SIVmac239m initiated ART on Day 42 post-infection and remained on ART for 55 weeks before starting two cycles of…

GLOBAL ORIGINS OF RESISTANCE-ASSOCIATED VARIANTS IN THE NS5A REGION OF HCV

By Enthusiast Inc MDFebruary 15, 2017

…FastTree2. Resulting phylogenies were rescaled to units of time using the R package ape. Next, we reconstructed the ancestral sequences at the nodes of the trees using MG94xREV codon model….

UNBIASED AND MULTIOMIC ASSESSMENT OF HIV-1–INFECTED CELLS AT SINGLE-CELL RESOLUTION

By Jimmy He PharmD, DScApril 4, 2022

…blood CD4+ T-cells; (2) chronic infection, lymph node memory CD4+ T-cells; and (3) ART treated, peripheral blood memory CD4+ T-cells. Cells were enriched by bead separation, labeled with oligo-tagged antibodies,…

URACIL TREATMENT DOES NOT INCREASE SUSCEPTIBILITY TO RECTAL SIV INFECTION

By Jimmy He PharmD, DScMarch 3, 2023

Background: The intestinal microbiome of men who have sex with men (MSM) is distinct as compared to non-MSM and is suggested to increase susceptibility to rectal HIV infection. Indeed, we…

472 – Compartmentalized Biomarker Correlations in HIV: Plasma-CSF Relationships

By Jimmy He PharmD, DScMarch 31, 2026

…highly connected biomarkers identified central nodes such as TNF and IFNG, and KEGG pathway enrichment highlighted cytokine–cytokine receptor and Toll-like receptor signaling as key cross-compartment mechanisms (Figure). Conclusions BBB integrity…

IMMUNE CORRELATES OF POSTTREATMENT CONTROL IN SHIV-INFECTED INFANT MACAQUES

By Jimmy He PharmD, DScApril 22, 2021

…(LN) were collected throughout the study for flow cytometry and viral measurements. Spearman correlations were used to identify associations between viral control and over 30 immune parameters measured pre-ATI. Pre-ATI…

SIV?GY INFECTION INDUCES ELITE CONTROL AND RESISTANCE TO SHIV HETEROLOGOUS CHALLENGE

By Jimmy He PharmD, DScApril 22, 2021

HIV reservoir persistence is an obstacle to cure. Elite controllers (ECs) suppress virus in the absence of anti-retroviral drugs. Immunologic mechanisms that lead to viral control and interventions that could…

←1
234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950515253545556575859606162636465
…6667686970…
717273747576777879808182
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top